US Tariffs on India: A Manageable Challenge or Economic Opportunity?
The US has announced tariffs impacting around USD 8.1 billion of India's exports, affecting sectors like engineering and electronics. Despite the tariffs, PHDCCI suggests the overall impact on India's economy remains minimal, presenting businesses with opportunities for export sophistication and market diversification amidst resilience in domestic demand.

- Country:
- India
The recent reciprocal tariffs announced by the US are set to affect approximately USD 8.1 billion worth of Indian exports. According to an analysis by the industry body PHDCCI, the impact on India's economy would be minimal, influencing only 1.87% of India's total global merchandise exports and having a negligible 0.19% effect on its GDP.
The analysis highlighted that sectors including engineering goods (USD 1.8 billion), electronics (USD 1.4 billion), pharmaceuticals (USD 986 million), gems and jewelry (USD 932 million), and readymade garments (USD 500 million) would be most affected. President Donald Trump announced a further increase in tariffs on Indian imports due to India's continued purchase of Russian oil.
Industry leaders emphasize that this tariff scenario underscores the need for India to enhance its export sophistication and diversify geographically. Despite the challenges, India's strong domestic demand and economic diversification afford resilience. PHDCCI's strategic framework suggests Indian businesses view this as an opportunity to innovate and expand into new markets for sustained competitiveness.
(With inputs from agencies.)
ALSO READ
Intas Pharmaceuticals Launches HETRONIFLY™ (Serplulimab), India's First Novel Immunotherapy for Advanced Small Cell Lung Cancer
LA Olympics chairman gifts three medals from 1984 Olympics to US President Donald Trump
The Kremlin says Russian President Vladimir Putin is meeting with US President Donald Trump's envoy Steve Witkoff, reports AP.
US President Donald Trump's first tranche of 25% tariffs on India comes into effect.
Australia Challenges Trump's Tariff Threats on Pharmaceuticals